Immobilized human TGF-β1 at 0.5 μg/ml (50μL/well) can bind to Fresolimumab with a linear range of 12.46 ng/ml to 10 μg/ml.
Product Details
Product Details
Product Specification
Host | Human |
Clone Number | S-SC006 |
Antibody Type | Recombinant mAb |
Application | Blocking of TGFβ signaling Functional assays |
Purification | Protein G |
Concentration | 2 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4, containing no preservative. |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
ELISA | 12.64-10000 ng/ml |
Background
Fresolimumab is a human monoclonal antibody and an immunomodulator. It is intended for the treatment of idiopathic pulmonary fibrosis (IPF), focal segmental glomerulosclerosis, and cancer (kidney cancer and melanoma). It binds to and inhibits all isoforms of the protein transforming growth factor beta (TGF-β).
Picture
Picture
ELISA
